Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'

Oncology (Switzerland)

Volumn 49, Issue 6, 1992, Pages 426-430

  Bartoloni, Carlo ^a   Guidi, Luisa ^a   Tricerri, Augusto ^a   Patriarca, Francesca ^a   Pili, Roberto ^a   Cursi, Flavio ^a   Canetta, Mattia ^a   Cappelli, Alessandra ^a   Vangeli, Marcello ^a   Salvati, Franco ^b   Gambassi, Gino ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Antithrombin III; Coagulation; Metastasis; Thrombin antithrombin III complexes; Tumour

Indexed keywords

ANTITHROMBIN; THROMBIN;

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; TUMOR GROWTH;

ANTITHROMBIN III; BLOOD COAGULATION DISORDERS; HUMAN; NEOPLASM METASTASIS; NEOPLASMS; PEPTIDE HYDROLASES; SUPPORT, NON-U.S. GOV'T;

EID: 0027103792     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227086     Document Type: Article

References (20)

1. Trousseau A: Phlegmasia alba dolens. Clin Med Hotel-Dieu (Paris) 1865. p 654.
2. Nand S, Messmore H: Hcmostasis in malignancy. Am J Hematol 1990; 35: 45-55.
3. Kies MS, Posch JJ, Giolma JP, Rubin RN: Hcmostatic function in cancer patients. Cancer 1980; 46: 831-837.
4. Soong BCF, Miller SP: Coagulation disorders in cancer. III. Fibrinolysis and Inhibitors. Cancer 1970; 25: 867-874.
5. Dvorak HF, Sanger DR, Dvorak AM: Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 1983; 2: 41-73.
6. Gordon SG, Benson B: Analysis of serum cancer procoagulant activity and its possible use as a tumor marker. Thromb Res 1989: 56: 431-440.
7. Francis J L, El-Baruni K, Gordon SG: Factor X activating activity and cancer procoagulant in malignant tissue. Abstr Book. 2nd Int Congr Advances in Management of Malignancies, Ascoli Piceno, 28 May-1 June 1990. p 62.
8. Camacho M, Fabra Fras A, Llorens A, Rutllant ML: Urokinase plasminogen activator in human tumours. Abstr Book Metastasis Congr, 2nd Int Conf Metastasis Research Society, Heidelberg. Sept 26-29. 1988. p 34.
9. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266.
10. Zacharski LR, Henderson WG, Rickless RF, Forman WB, Cornell CJJ, Forcier RJ, Edwards R, Headley E, Kim SH, O'Donnel JR, O'Dell R, Tornyos K, Kwaan HC: Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No 75. JAMA 1981; 245: 831-835.
11. Zacharski LR, Henderson PD, Rickies FR, Forman WB, Cornell CJ, Forcier RJ, Edwards R L, Headley E, Kim S H, O'Donnell J F, et al: Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck and prostate. Final Report of VA cooperative study No 75. Cancer 1984; 53: 2046-2051.
12. D'Souza DP, Daly L, Thornes RD: Increased survival in advanced breast cancer with warfarin, B.C.G., and levamisole as adjuvants to chemotherapy. Int Med J 1978; 71: 605-608.
13. Neumann S, Gunzer G, Hennrich N, Lang H: PMN-elastase assay: enzyme immonoassay for human PMN clastasc complexed with proteinase inhibitors. J Clin Chem Clin Biochem 1984; 22: 693-697.
14. Brower MS, Harpel PC, Alpha 1-antitrypsinhuman leukocyte elastase complexes in blood: Quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes. Blood 1983; 61: 842-849.
15. Bartoloni C, Guidi L, Marciano M, Patriarca F, Gentiloni N, Pili R, Cursi F, Gambassi G: Thrombin-antithrombin complexes in human canoer. Abstr Book 10th Meet Eur Assoc Cancer Res, Galway, Sept 10-13. 1989, p 16.
16. Asakura H, Saito M, Ito K, Jokaji Y, Uotani C, Ichiro K, Matsuda T: Levels of thrombin-antithrombin III complexes in plasma in cases of acute promyelocytic leukemia. Thromb Res 1988; 50: 895-899.
17. Wagner C, Dati F, Pelzer H: Quantitation of hypercoagulability associated with malignancies by thrombin-antithrombin III complexes. Abstr Book 2nd Int Congr Adv Management of Malignancies. Ascoli Piceno, 28 May-1 June. 1990, p 149.
18. Patterson WP, Ringenbcrg QS: The pathophysiology of thrombosis in cancer. Semin Oncol 1990; 17: 140-146.
19. Kataghiri Y, Hayashi Y, Baba I, Suzuki H, Tanoue K, Yamazaki H: Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: Roles of heparin, plasma adhesive proteins and tumor cell membrane proteins. Cancer Res 1991; 51: 1286-1293.
20. Brown JM: A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases. Cancer Res 1973; 33: 1217-1224.